Pricing
  1. JP-listed companies
  3. Financials
  4. Cost of revenue

【JP:3417】

Market cap
¥19B
P/E ratio
Oki Healthcare Holdings manages a pharmaceutical group of eight companies that manufacture and sell medicines and related products for the healthcare industry.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 2025330,942+4.25%
Mar 31, 2024317,460+10.01%
Mar 31, 2023288,563+9.12%
Mar 31, 2022264,437+3.06%
Mar 31, 2021256,584+2.90%
Mar 31, 2020249,345+7.21%
Mar 31, 2019232,582+8.03%
Mar 31, 2018215,284+7.46%
Mar 31, 2017200,348+6.98%
Mar 31, 2016187,280

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)